Active ingredient
Iobitridol 300/350 mg/ml
Medical indication
Röntgen Kontrastmittel
Pharma Company
Guerbet GmbH
Total Number of Doctors1
183 doctors
Total Number of Patients2
94,765 patients
Total minimum fees planned3
947,650.00 €

Observational Studies including Xenetix

Drug No. of doctors1 No. of patients2 Payment per patient3
Xenetix 250/300/350 183 94,765 10.00 € bis 20 pro ausgefülltem Dokumentationsbogen
Xenetix 300/350 n/a n/a n/a Meldung vor Anzeigenpflicht


Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.